In a remarkable development, the progressive wave of medicinal cannabis has found its way to the equestrian world, with CannaHorse poised to lead the charge in offering an alternative to conventional pain relief pharmaceuticals for horses. In a trailblazing move, CannaHorse is on the brink of introducing a range of cannabis-based products designed to address pain relief, inflammation, anxiety, exercise recovery, and surgical recuperation in horses.
Warren Byrne, President of CannaHorse, expresses the collective vision with fervor, emphasizing the potential of cannabis and cannabinoids to revolutionize equine health. Byrne affirms, “We recognize the opportunity to bring the transformative power of cannabis and cannabinoids we see working in humans and other animals to life for horses.”
As this groundbreaking endeavour takes shape, Dr. Michael Lindinger assumes a pivotal role. Dr. Lindinger, President of the Nutraceutical Alliance and a former professor at the University of Guelph, is set to oversee the upcoming clinical trials scheduled for the fall. With the Nutraceutical Alliance’s expertise in translating science into effective product formulations, the guidance from both Dr. Lindinger and the Alliance promises to be instrumental in advancing CannaHorse’s mission.
The demand from horse owners for a pain relief product devoid of negative side effects is undeniable. Dr. Lindinger sheds light on the shortcomings of traditional pain medications for horses, citing their propensity to cause ulcers in the stomach and intestines, as well as damage to joints. Against this backdrop, CannaHorse’s cannabis-based solutions hold the potential to reshape the landscape of equine pain management.
The impending clinical trials, under the vigilant oversight of Dr. Lindinger and the Nutraceutical Alliance, are anticipated to shed light on the efficacy of CBD medication in horses. Beyond its pain-relieving properties, the trials will closely examine the impact on equine behavior during medication. The collective perspective on the significance of this venture is profound, as both parties point out, “It’s so important to do it for horses because there is no research that has been done in horses using any of the cannabinoids. It is an important first step.”
As CannaHorse harnesses the transformative potential of cannabis for equine well-being, it echoes the ethos of The Nutraceutical Alliance, an institution dedicated to elevating products through scientific rigor. This convergence of innovative vision and scientific expertise paves the way for a new era in equine health, solidifying the importance of the collaboration between CannaHorse and the Nutraceutical Alliance in advancing the frontiers of animal well-being.